Literature DB >> 30083825

90Y-radioembolization of hepatocellular carcinoma from a theranostic perspective: towards a personalized approach.

Luca Filippi1, Orazio Schillaci2,3, Oreste Bagni4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30083825     DOI： 10.1007/s00259-018-4115-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  6 in total

1.  Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.

Authors:  Riad Salem; Robert J Lewandowski; Laura Kulik; Edward Wang; Ahsun Riaz; Robert K Ryu; Kent T Sato; Ramona Gupta; Paul Nikolaidis; Frank H Miller; Vahid Yaghmai; Saad M Ibrahim; Seanthan Senthilnathan; Talia Baker; Vanessa L Gates; Bassel Atassi; Steven Newman; Khairuddin Memon; Richard Chen; Robert L Vogelzang; Albert A Nemcek; Scott A Resnick; Howard B Chrisman; James Carr; Reed A Omary; Michael Abecassis; Al B Benson; Mary F Mulcahy
Journal:  Gastroenterology       Date:  2010-10-30       Impact factor: 22.682

2.  Radioembolization with 90Y glass microspheres for hepatocellular carcinoma: significance of pretreatment 11C-acetate and 18F-FDG PET/CT and posttreatment 90Y PET/CT in individualized dose prescription.

Authors:  Chi Lai Ho; Sirong Chen; Shing Kee Cheung; Yim Lung Leung; Kam Chau Cheng; Ka Nin Wong; Yuet Hung Wong; Thomas Wai Tong Leung
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-06-11       Impact factor: 9.236

Review 3.  Imaging of primary liver tumors with positron-emission tomography.

Authors:  Alexander R Haug
Journal:  Q J Nucl Med Mol Imaging       Date:  2017-09       Impact factor: 2.346

4.  Decrease in total lesion glycolysis and survival after yttrium-90-radioembolization in poorly differentiated hepatocellular carcinoma with portal vein tumour thrombosis.

Authors:  Luca Filippi; Giovan G Di Costanzo; Antonio D'Agostini; Raffaella Tortora; Giuseppe Pelle; Roberto Cianni; Orazio Schillaci; Oreste Bagni
Journal:  Nucl Med Commun       Date:  2018-09       Impact factor: 1.690

5.  The prognostic value of 18F-FDG PET/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE).

Authors:  Wenhui Ma; Jia Jia; Shengjun Wang; Wei Bai; Jingwei Yi; Ming Bai; Zhiyong Quan; Zhanxin Yin; Daiming Fan; Jing Wang; Guohong Han
Journal:  Theranostics       Date:  2014-05-01       Impact factor: 11.556

6.  It is time to move forward into the era of Theranostics.

Authors:  Hojjat Ahmadzadehfar; Markus Essler
Journal:  EJNMMI Res       Date:  2018-01-30       Impact factor: 3.138
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.